Comparison of PD-L1 Assays in Non-small Cell Lung Cancer: 22C3 pharmDx and SP263.
Fujimoto D, Yamashita D, Fukuoka J, Kitamura Y, Hosoya K, Kawachi H, Sato Y, Nagata K, Nakagawa A, Tachikawa R, Date N, Sakanoue I, Hamakawa H, Takahashi Y, Tomii K.
Fujimoto D, et al. Among authors: sakanoue i.
Anticancer Res. 2018 Dec;38(12):6891-6895. doi: 10.21873/anticanres.13065.
Anticancer Res. 2018.
PMID: 30504406